Salix Pharmaceuticals

RELISTOR

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / RELISTOR – J2212

Manufacturer:

Salix Pharmaceuticals

Name:

RELISTOR

HCPCS Code Descriptor:

Injection, methylnaltrexone, 0.1 mg

Category:

J Code

HCPCS:

J2212

NDC(s):

65649-0551-07, 65649-0552-04, 65649-0551-02, 65649-0551-03

Primary Type:

Gastrointestinal

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

RELISTOR is a Gastrointestinal drug manufactured by Salix Pharmaceuticals and administered via the Subcutaneous route of administration. The J Code: J2212 is aligned to the drug RELISTOR.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/13

HCPCS Effective Date:

1/1/13

HCPCS Short Description:

Methylnaltrexone injection

Billing and Coding Guide:

Not Found

Patient Assistance:

http://www.bauschhealthpap.com

http://www.bauschhealthpap.com